News

US biotech BioMarin Pharmaceutical (Nasdaq: BMRN) has presented new five-year data from its pivotal Phase III trial of ...
The deal marks Phenna Group’s tenth transaction of 2025 and brings its portfolio in the Asia-Pacific region to sixteen businesses.
BioMarin Pharma has decided not to divest its haemophilia A gene therapy Roctavian, which has struggled to build much traction in the market, but is reining back its ambitions for the business.
Nottingham-headquartered Phenna Group has made its 10th acquisition of 2025, swooping for Asset Management Engineers.
James Island residents have reported a water outage caused by a water main break on Tuesday night. The outage started around 8 p.m. in the area of Dills Bluff Road and in and around Lawton Bluff ...